- A Case of Primary Adrenal Diffuse Large B-cell Lymphoma Achieving Complete Remission with Rituximab-CHOP Chemotherapy
-
Kim KM, Yoon DH, Lee SG, Lim SN, Sug LJ, Huh J, Suh C
- KMID: 1779176
- J Korean Med Sci.
- 2009 Jun;24(3):525-528.
- doi: 10.3346/jkms.2009.24.3.525
Primary adrenal lymphoma is a very rare extranodal lymphoma; its clinical features consist of a high incidence of bilateral adrenal involvement and diffuse large B-cell lymphoma. We report a patient... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Synchronous Early Gastric Cancer and Diffuse Large B Cell Lymphoma Treated with Endoscopic Submucosal Dissection and Chemotherapy
-
Park JH, Jang JY, Cho YD, Dong SH, Kim HJ, Kim BH, Chang YW
- KMID: 1792838
- Korean J Gastroenterol.
- 2012 May;59(5):377-381.
- doi: 10.4166/kjg.2012.59.5.377
Among malignant tumors of the stomach, adenocarcinoma takes up about 95% and the remaining are mostly lymphomas, being less than 5%. The majority of lymphomas are B cell lymphomas, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Comparison of Chemotherapy and Surgery for Early Stage Diffuse Large B-cell Gastric Lymphoma
-
Kim SJ, Cheong JW, Hahn JS
- KMID: 1786207
- Yonsei Med J.
- 2007 Dec;48(6):942-948.
- doi: 10.3349/ymj.2007.48.6.942
PURPOSE: The use of surgery versus stomach-preserving treatment for primary gastric lymphoma has caused controversy among doctors. This retrospective, single center study aims to evaluate the efficacy and benefit... -
- CITED
-
- Close
- SHARE
-
- Close
- Late-onset Neutropenia Following Rituximab Therapy as a Treatment of Diffuse Large B-cell Lymphoma: A Single Institution Study
-
Kim M, Lee JK, Hong YJ, Hong SI, Kang HJ, Chang YH
- KMID: 1781661
- Korean J Lab Med.
- 2010 Dec;30(6):575-579.
- doi: 10.3343/kjlm.2010.30.6.575
BACKGROUND: Late-onset neutropenia (LON) following rituximab therapy has been reported in recent years. However, its incidence has not been reported in Korea. The aim of this study is to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- Fulminant Hepatic Failure with Hepatitis B Virus Reactivation after Rituximab Treatment in a Patient with Resolved Hepatitis B
-
Chung SM, Sohn JH, Kim TY, Yoo KD, Ahn YW, Bae JH, Jeon YC, Choi JH
- KMID: 1792779
- Korean J Gastroenterol.
- 2010 Apr;55(4):266-269.
- doi: 10.4166/kjg.2010.55.4.266
It is well known that the reactivation of hepatitis B virus (HBV) may occur as an acute hepatitis after chemotherapy or immunosuppressive therapy. Although most of these cases have been... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Therapy-Related Acute Leukemia With Mixed Phenotype With BCR-ABL1 After Treatment of Diffuse Large B-Cell Lymphoma
-
Yang D, Cho SR, Jung S, Lee W, Hwang HY, Lee HS, Kim YS, Choi JR, Kim MH
- KMID: 2373637
- Ann Lab Med.
- 2017 Mar;37(2):166-168.
- doi: 10.3343/alm.2017.37.2.166
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
-
Choi YW, Jeong SH, Ahn MS, Lee HW, Kang SY, Choi JH, Jin UR, Park JS
- KMID: 2069930
- J Korean Med Sci.
- 2014 Nov;29(11):1493-1500.
- doi: 10.3346/jkms.2014.29.11.1493
Febrile neutropenia (FN) is the major toxicity of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen in the treatment of diffuse large B-cell lymphoma (DLBCL). The prediction of neutropenia... -
- CITED
-
- Close
- SHARE
-
- Close
- Modified Number of Extranodal Involved Sites as a Prognosticator in R-CHOP-Treated Patients with Disseminated Diffuse Large B-Cell Lymphoma
-
Yoo C, Kim S, Sohn BS, Kim JE, Yoon DH, Huh J, Lee DH, Kim SW, Lee JS, Suh C
- KMID: 1776612
- Korean J Intern Med.
- 2010 Sep;25(3):301-308.
- doi: 10.3904/kjim.2010.25.3.301
BACKGROUND/AIMS: Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (R-CHOP) has improved survival in patients with diffuse large B-cell lymphoma (DLBCL) and weakened the prognostic power of the international prognostic... -
- CITED
-
- Close
- SHARE
-
- Close
- Gemcitabine, Etoposide, Cisplatin, and Dexamethasone in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
-
Kim KH, Joo YD, Sohn CH, Shin HJ, Chung JS, Cho GJ, Shin SH, Kim YS, Lee WS
- KMID: 1785640
- Korean J Intern Med.
- 2009 Mar;24(1):37-42.
- doi: 10.3904/kjim.2009.24.1.37
BACKGROUND/AIMS: To date, an effective salvage chemotherapy regimen for the treatment of refractory or relapsing non-Hodgkin's lymphoma (NHL) has not been discovered. This study was conducted to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
